Title : Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) study.

Pub. Date : 2017 Jul

PMID : 28463756






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ETS represents an early parameter associated with the benefit from anti-EGFR, while this was not the case with vascular endothelial growth factor A blockade. ets epidermal growth factor receptor Homo sapiens